Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results


1.		A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				06/34 NCT00431990


2.		A Single Agent Phase II Study of Depsipeptide (FK228) in the Treatment of Cutaneous T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				GPI-04-0001 NCT00106431


3.		A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				Not specified				Other				CCR2742 NCT00299351

Last Modified: 9/22/2006 First Published: 7/7/2006


4.		Phase II Study of FR901228 in Patients With Relapsed or Refractory Mantle Cell or Diffuse Large Cell Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				MDA-2005-0579 7869, NCI-7869, NCT00383565


5.		A Trial of Romidepsin for Progressive or Relapsed Peripheral T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				GPI-06-0002 NCT00426764


6.		Trial of Romidepsin and Bortezomib for Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				GPI-08-0006 NCT00765102

Last Modified: 10/31/2008 First Published: 7/1/2002


7.		Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Subjects with Pulmonary and Pleural Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				NCI-02-C-0205 NCI-5270, 5270, NCT00041158

Last Modified: 1/29/2008 First Published: 11/24/2002


8.		Phase I Study of FR901228 (Romidepsin) in Patients With Advanced Cancer (Closed to Accrual as of 1/28/08) or Radioiodine-Refractory Non-Medullary Thyroid Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				NCI-03-C-0030 NCI-5483, 5483, NCT00052767

Last Modified: 12/9/2008 First Published: 11/22/2004


9.		Phase I Study of FR901228 (Depsipeptide) and Flavopiridol in Patients With Advanced Primary Lung or Esophageal Cancer, Malignant Pleural Mesothelioma, or Lung or Pleural Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				NCI				NCI-05-C-0010 5987, NCI-5987, NCT00098644

Last Modified: 3/27/2008 First Published: 5/21/2007


10.		Phase I Pilot Study of Topical Romidepsin in Patients With Stage IA, IB, or IIA Cutaneous T-Cell Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 to 100				NCI				NCI-07-C-0133 07-C-0133, 7860, NCT00477698

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute